Karolinska University Hospital: clinical-trial pipeline
Karolinska University Hospital is the sponsor of 308 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 78 are not yet finished and 3 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 213 |
| Phase 2 | 33 |
| Phase 3 | 21 |
| Phase 4 | 17 |
| Phase 1 | 12 |
| Phase 1/2 | 9 |
| Phase 2/3 | 2 |
| Early phase 1 | 1 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 147 |
| Unknown | 69 |
| Recruiting | 45 |
| Not yet recruiting | 21 |
| Active, not recruiting | 12 |
| Terminated | 7 |
| Withdrawn or not authorised | 4 |
| Suspended or halted | 3 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 77 |
| Cardiovascular | 44 |
| Gastroenterology and liver | 32 |
| Infectious disease and vaccines | 27 |
| Metabolic and endocrine (diabetes, obesity) | 24 |
| Respiratory | 23 |
| Rare and genetic diseases | 18 |
| Nephrology and urology | 16 |
| Dermatology | 13 |
| Women's health and obstetrics | 13 |
| Musculoskeletal | 12 |
| Neurology | 11 |
Countries
| Country | Trials |
|---|---|
| Sweden | 278 |
| Norway | 7 |
| Tanzania | 7 |
| Denmark | 6 |
| Finland | 4 |
| Netherlands | 4 |
| Switzerland | 2 |
| Germany | 2 |
| United Kingdom | 2 |
| Ireland | 2 |
| Iceland | 2 |
| Italy | 2 |
| Austria | 1 |
| Australia | 1 |
| Belgium | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-09-11 | New trial posted | Prognostic Evaluation and Systematic Re-Assessment of Cholangiocarcinoma Therapy |
| 2026-09-10 | New trial posted | SCARP-DIAL (SGLT2i for CARdiovascular Protection in DIALysis) |
| 2026-09-02 | New trial posted | Validation of Myocardial Perfusion and Extracellular Volume Assessment Using Photon-Count… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| 2024-511651-17-00 | A phase II multicenter single-armed study using subject-specific minimal residual minimal disease markers to… | Phase 2 | Recruiting | Denmark, Finland, Norway, Sweden |
| 2023-509019-97-00 | HEAT-AML (Hydroxyurea-Enhanced Ara-C Treatment of Adult Acute Myeloid Leukaemia): A phase I/II multi-centre s… | Phase 1/2 | Active, not recruiting | Sweden |
| 2023-509534-18-01 | HEMO trial - A randomized controlled trial of heparin bolus mobilization prior to peripheral hematopoietic ce… | Phase 2 | Not yet recruiting | Sweden |
| 2024-513388-16-00 | PARACHUTES: Pedophilia At Risk – Acute Treatment – E-therapy vs SSRI | Phase 2 | Recruiting | Sweden |
| NCT05172310 | PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI | Phase 1 | Recruiting | Finland, Sweden |
| 2024-515271-35-00 | Intralymfatisk immunterapi förstärkt av vitamin-D, en randomiserad placebokontrollerad studie och jämförelse… | Phase 2/3 | Active, not recruiting | Sweden |
| NCT04856488 | Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter | Phase 3 | Recruiting | Sweden |
| NCT06639191 | [177Lu]Lu-AKIR001 First-in-human Study | Early phase 1 | Recruiting | Sweden |
| NCT05649605 | Early Mental Response - The EMRE Study | Not applicable | Not yet recruiting | Sweden |
| NCT04307576 | A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia | Phase 3 | Recruiting | Belgium, Germany, Denmark, Estonia +11 |
| 2024-514866-37-01 | Cell-based immunotherapy in solid organ transplantation to minimize systemic immunosuppression | Phase 1/2 | Recruiting | Sweden |
| NCT05328258 | Use of GnRHa During Chemotherapy for Fertility Protection | Phase 3 | Not yet recruiting | Sweden |
| 2024-515250-25-00 | K-SAB trial | Phase 1 | Not yet recruiting | Sweden |
| NCT02603679 | Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases | Phase 2 | Active, not recruiting | Sweden |
| 2024-518775-54-00 | Utvärdering av två kortison behandlingsstrategier hos patienter med nydiagnostiserad, tidigare obehandlad reu… | Phase 4 | Recruiting | Sweden |
| NCT06830382 | HER2-PET as a Precision Imaging Tool for Treatment With HER2-ADC in HER2-expressing mBC | Not applicable | Recruiting | Sweden |
| NCT03085771 | Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes | Phase 2 | Recruiting | Sweden |
| NCT05586724 | Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Ther… | Phase 3 | Not yet recruiting | Sweden |
| 2024-519060-40-00 | A study of safety, feasibility and immunologic response of transfering tumor infiltrating lymphocytes with or… | Phase 1 | Not yet recruiting | Sweden |
| 2023-508196-36-00 | Primary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and ri… | Phase 2 | Recruiting | Denmark, Finland, Iceland, Norway +1 |
| 2024-519593-39-00 | SWE-NEO: Swedish NeoAdjuvant Trial Comparing anti-PD-1 Monotherapy to Combined anti-CTLA-4/anti-PD-1 blockade… | Phase 3 | Recruiting | Sweden |
| NCT07514767 | Evaluation of the Efficacy and Safety of Nivolumab Neoadjuvant Treatment of Patients With Locally Advanced Or… | Phase 2 | Recruiting | Sweden |
| 2024-517279-20-02 | Levosimendan in Cardiac Arrest: A Randomized Double-blinded Clinical Phase II Trial (LeICA) | Phase 2 | Recruiting | Sweden |
| 2024-520231-33-00 | A three-way cross-over phase IIa trial using L-citrulline and folic acid in combination with vericiguat and t… | Phase 2 | Not yet recruiting | Sweden |
| 2024-514879-17-00 | Randomised Phase III Trial of First Line Intraperitoneal Paclitaxel and Systemic Therapy versus Systemic Ther… | Phase 3 | Recruiting | Italy, Netherlands, Norway, Sweden |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Karolinska University Hospital clinical trials: 78 open, 23 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/karolinska-university-hospital/, data as of 2026-10-25.